Interestingly, features of systemic disease—such as arthritis, anti-DNA antibodies, nephritis, and low complement—were only significantly associated with the co-elevation of the three IFN types (Figure 3D; Table S6), suggesting an additive effect of the three IFN families in severe SLE. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.